Urodelia is the subject of an article in Biotech Finances (issue 861). Indeed, its Business Development in Animal Health partnership with 4P-Pharma represents a new phase in its deployment. 4P-Pharma, a French biotechnology company specializing in the development of drugs for humans and animals, will identify strategic opportunities in animal health for the licensing of ∞